Condition
Hemophilia B
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownDevelopment of Non-Invasive Prenatal Diagnosis for Single Gene DisordersNCT06147414 · 2024-10-23
RECRUITINGBaby Detect : Genomic Newborn ScreeningNCT05687474 · 2022-09-01
COMPLETEDMedication Adherence and Non-adherence in Adults With Rare DiseaseNCT04541875 · 2021-01-01
WITHDRAWNEarly Check: Expanded Screening in NewbornsNCT03655223 · 2018-10-15
ACTIVE_NOT_RECRUITINGAn Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With HemophiliaNCT02199717 · 2013-09-01
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED2
ACTIVE_NOT_RECRUITING1
RECRUITING1
WITHDRAWN1
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.